DEBORAH MISTAL: Open Payments
NPI 1033280417 · DRUMS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 6 payments from 3 companies in 2025. Trend: 2023 $294 · 2024 $313 · 2025 $367
Food & beverage: $351Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $194 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
Products named: UPTRAVI, FARXIGA, AIRSUPRA, JARDIANCE, BREZTRI.
Industry payments across PA — which companies pay providers there.
